
Abbott Laboratories (NYSE: ABT)
Abbott Laboratories Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Abbott Laboratories Company Info
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
News & Analysis
5 Dividend Aristocrats® So Good You'll Never Want to Sell
Turn $180 into $7M? These 5 Dividend Aristocrats show how it's possible.
The Largest Healthcare Companies by Market Cap in April 2025
Eli Lilly, UnitedHealth Group, and Johnson & Johnson command the healthcare sector.
Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday
Dividend Kings of 2025
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
20 High-Yield Dividend Stocks to Buy in 2025
A list of high-yielding dividend stocks to consider buying now.
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
These companies' longtime shareholders have generally been rewarded.
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
These stocks could deliver big over the long term.
Is Abbott Laboratories Stock a Buy?
The healthcare stock is lagging the market this year.
Valuation
Earnings Transcripts
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2024.
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2024.
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
ABT earnings call for the period ending June 30, 2024.
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
ABT earnings call for the period ending March 31, 2024.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.